Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines : mise au point et recommandations nationales du GPCO-Unicancer et du RNPGx-Reference-Cited by-同舟云学术

Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines : mise au point et recommandations nationales du GPCO-Unicancer et du RNPGx

Published:2018-04 Issue:4 Volume:105 Page:397-407
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Loriot Marie-Anne,Ciccolini Joseph,Thomas Fabienne,Barin-Le-Guellec Chantal,Royer Bernard,Milano Gérard,Picard Nicolas,Becquemont Laurent,Verstuyft Céline,Narjoz Céline,Schmitt Antonin,Bobin-Dubigeon Christine,Harle Alexandre^ORCID,Paci Angelo,Poinsignon Vianney^ORCID,Quaranta Sylvie,Evrard Alexandre,Hennart Benjamin,Broly Franck,Fonrose Xavier,Lafay-Chebassier Claire,Wozny Anne-Sophie,Masskouri Fadil,Boyer Jean-Christophe,Etienne-Grimaldi Marie-Christine^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference42 articles.

1. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stages II and III colon cancer: results of a randomized trial;Andre;J Clin Oncol,2003

2. 5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency;Boisdron-Celle;Cancer Lett,2007

3. New advances in DPYD genotype and risk of severe toxicity under capecitabine;Etienne-Grimaldi;PLoS One,2017

4. Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: assessment of a multiparametric approach;Boisdron-Celle;Semin Oncol,2017

5. Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity;Tuchman;N Engl J Med,1985

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy;Strahlentherapie und Onkologie;2024-09-04

2. Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study;Cancer Chemotherapy and Pharmacology;2024-07-10

3. A fatal case of 5-FU toxicity despite dose adjustment in a patient with a partial DPD deficiency receiving the FLOT regimen;European Journal of Cancer;2024-07

4. Characterization of Reference Materials for DPYD;The Journal of Molecular Diagnostics;2024-07

5. DPYD Genotyping Recommendations;The Journal of Molecular Diagnostics;2024-07